Avantor | Jotup

Thomas Scientific Appoints Stan Haas to President and Chief Executive Officer

Retrieved on:

Tuesday, April 25, 2023

General Electric, University, University of St. Thomas (Minnesota), MBA, Research, Science, University of Wisconsin–Madison School of Education, Acquisition, Avantor, Pleasure, Haas, Microbiology, Management

SWEDESBORO, N.J., April 25, 2023 /PRNewswire/ -- Thomas Scientific, the most trusted supplier to the scientific community, today announced that Stan Haas has been appointed to President and Chief Executive Officer. Joining the company in 2017, Haas first served on the Board of Directors and then on the executive team as Chief Operating Officer. He brings more than 30 years of experience in the scientific-distribution industry, including executive-leadership positions in sales, operations, strategy and business development, and services and global sourcing, along with extensive international experience. Known for building high-performing teams and delivering results, Haas is passionate about the scientific business and its critical role in fueling innovation in life sciences, biopharma, research, and microelectronics.

Key Points:

SWEDESBORO, N.J., April 25, 2023 /PRNewswire/ -- Thomas Scientific , the most trusted supplier to the scientific community, today announced that Stan Haas has been appointed to President and Chief Executive Officer.
Joining the company in 2017, Haas first served on the Board of Directors and then on the executive team as Chief Operating Officer.
"I'm excited to continue driving Thomas Scientific in my new role as President and CEO, especially given our unique position to leverage our rich heritage and industry expertise in this ever-evolving scientific environment," said Haas.
Prior to joining Thomas Scientific, Haas served as COO at Affiliated Distributors, North America's largest buying-group organization for construction and industrial supplies.

Avantor® Announces Supplier Award Winners at Americas Sales Conference

Retrieved on:

Tuesday, April 18, 2023

Quanta, Equipment, Avantor, AVTR, Education, Marketing, TWD, Government, Science, Chemical substance, Chemistry, Growth, International Suppliers Network, Conference, NYSE, Oxford Nanopore Technologies, Auction, Fine chemical

The Americas Sales Conference is an important forum that strengthens collaboration among suppliers and across Avantor's sales organization to achieve growth opportunities.

Key Points:

The Americas Sales Conference is an important forum that strengthens collaboration among suppliers and across Avantor's sales organization to achieve growth opportunities.
Avantor's suppliers are crucial partners, providing expanded choice with innovative and differentiated products that enable customers to continue advancing science from discovery to delivery.
The Avantor Supplier Awards recognize winners across a range of categories and product segments.
"Every year, I look forward to interacting with all of our suppliers and associates at Avantor's Americas Sales Conference.

Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition

Retrieved on:

Monday, April 3, 2023

Gene, Education, Head, ABEA, Best, BEA, Government, Risk, Cell, IMEA, Vaccine, Fine chemical, Chromatography, Avantor

Ganesh Bade - Head of Biopharma India Middle East & Africa (IMEA), Avantor (right) receiving the accolade at the Awards ceremony.

Key Points:

Ganesh Bade - Head of Biopharma India Middle East & Africa (IMEA), Avantor (right) receiving the accolade at the Awards ceremony.
Avantor is focused on making valuable contributions to cell and gene therapy production and offers expertise, technology capabilities and commitment to providing solutions.
Recently, Avantor was also accorded the Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards (ABEA) 2023 (bit.ly/3ZuSbUM) held in Singapore.
Ganesh Bade, Head Biopharma India Middle East and Africa (IMEA) at Avantor, said, "Cell and gene therapy is considered a game-changer for the biopharma industry.

Avantor® to Host First Quarter 2023 Earnings Call on Friday, April 28, 2023

Retrieved on:

Tuesday, April 4, 2023

Government, Webcast, Avantor, AVTR, Education, NYSE, Pharmaceutical industry, Broadcasting

RADNOR, Pa., April 4, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that it will release its first quarter 2023 financial results before the market opens on Friday, April 28, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.

Key Points:

RADNOR, Pa., April 4, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that it will release its first quarter 2023 financial results before the market opens on Friday, April 28, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.
To hear a live audio webcast of the earnings call, visit Events & Presentations on the Investor section of Avantor's website, ir.avantorsciences.com .
A replay of the webcast will be available for 30 days.

Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards

Retrieved on:

Thursday, March 16, 2023

SEAT, Drug development, International Fertilizer Development Center, Education, Chromatography, Government, ABEA, Avantor, Biotechnology, Acceleration, Fine chemical

Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables

Key Points:

Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables
Singapore, Mar 16, 2023 - (ACN Newswire) - Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, education, government and advanced technologies & applied materials industries, has been accorded the Best Bioprocessing Company for Chromatography at the Asia-Pacific Bioprocessing Excellence Awards 2023 (ABEA).
With over four decades of experience in bioprocessing, Avantor is committed to addressing the complex challenges of downstream chromatography by providing a comprehensive range of equipment, products and services.
"Chromatography is one of the most important components in enabling scientific breakthroughs and bringing promising biologics to market effectively.
"We are exceptionally proud to have been selected by the panel of industry experts and honored at this year's ceremony as the Best Bioprocessing Company - Chromatography.

Avantor® to Present at Upcoming Investor Conferences

Retrieved on:

Tuesday, February 28, 2023

Avantor, NYSE, Raymond James Financial, Webcast, AVTR, Raymond, Cowen

RADNOR, Pa., Feb. 28, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that management will present at two upcoming investor conferences.

Key Points:

RADNOR, Pa., Feb. 28, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that management will present at two upcoming investor conferences.
Thomas Szlosek, Chief Financial Officer, will present at the Raymond James 44th Annual Institutional Investors conference in Orlando, Fla. on Monday, March 6 at 1:40 p.m. Eastern Standard Time.
Michael Stubblefield, President & CEO, will participate in a fireside chat at Cowen's 43rd Annual Health Care conference in Boston, Mass.
To hear live audio webcasts of these upcoming sessions, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .

Avantor® Reports Fourth Quarter and Full-Year 2022 Results

Retrieved on:

Friday, February 3, 2023

RADNOR, Pa., Feb. 3, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, today reported financial results for the fourth quarter and year ended December 31, 2022.

Key Points:

"With fourth quarter results coming in line with expectations outlined on our third quarter earnings call, we realized core organic growth across all regions and delivered strong margin expansion despite ongoing macroeconomic pressures and customer destocking.
For the three months ended December 31, 2022, net sales were $1.80 billion, a decrease of 5.9% compared to the fourth quarter of 2021.
Operating cash flow in the quarter was $205.6 million, while free cash flow in the quarter was $172.0 million.
Net sales were $617.2 million, a reported decrease of 10.1%, as compared to $686.2 million in the fourth quarter of 2021.

Adam P. Crandall appointed Chief Revenue Officer by Addtronics Board of Directors

Retrieved on:

Monday, January 30, 2023

Marketing, Dynamics, VWR International, Growth, Avantor, DDS, Family, Management

CHARLOTTE, N.C., Jan. 30, 2023 /PRNewswire/ -- Addtronics, LLC ("Addtronics"), a mission-driven holding company dedicated to acquiring, empowering, and growing leading robotic automation solution providers, announced today the appointment of Adam P. Crandall as Chief Revenue Officer effective January 1st, 2023.

Key Points:

CHARLOTTE, N.C., Jan. 30, 2023 /PRNewswire/ -- Addtronics, LLC ("Addtronics"), a mission-driven holding company dedicated to acquiring, empowering, and growing leading robotic automation solution providers, announced today the appointment of Adam P. Crandall as Chief Revenue Officer effective January 1st, 2023.
In this newly created role, Adam will be responsible for all Addtronics commercial functions with the goal of accelerating growth and expanding market share.
Mr. Crandall previously led the commercial team at Dynamic Design Solutions, LLC ("DDS"), a member of the Addtronics family of companies.
Jerry Osborn, President of Addtronics stated, "I'm excited to bring Adam on board to lead our growing commercial organization.

Avantor® and Avantor Foundation Giving Supports Communities Around the Globe in 2022

Retrieved on:

Wednesday, January 18, 2023

RANDOR, Pa., Jan. 18, 2023 /PRNewswire/ -- Avantor Foundation, the philanthropic arm of Avantor, Inc. (NYSE: AVTR), today announced that it has surpassed $7 million in giving since its inception in 2009, supporting its mission of advancing science education and providing healthcare to those in need. In 2022, the Foundation granted more than $1 million to 15 organizations around the world. In addition, Avantor Inc. donated products to support education and disaster relief efforts valued at more than $1.3 million.

Key Points:

In 2022, the Foundation granted more than $1 million to 15 organizations around the world.
In addition, Avantor Inc. donated products to support education and disaster relief efforts valued at more than $1.3 million.
"We look forward to partnering with grantees and employees around the globe to extend our impact in 2023."
As part of Avantor's commitment to serving communities, Avantor Foundation recently expanded community engagement programming for Avantor employees to include matching gifts for both financial donations and volunteer time.

Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement

Retrieved on:

Monday, January 9, 2023

Patient, NYSE, CTLT, Catalent, Science, Global health, Avantor

Under the terms of the agreement, Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies' existing relationship.

Key Points:

Under the terms of the agreement, Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies' existing relationship.
"We look forward to deepening our work with the Avantor team to bring current and novel treatments to patients around the world."
"We are pleased to expand our support for Catalent and enable efficiencies to accelerate science for their customers around the globe."
This expanded relationship reflects Avantor's long history of providing customers with choice, reliability and innovative solutions.